FDA Authorizes First Molecular Nonprescription, At-Home Test
The product is a molecular nucleic acid amplification test that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils.
Read MorePosted by Laurie Bonner | Mar 5, 2021 | Covid 19, POC Reagents & Test Kits |
The product is a molecular nucleic acid amplification test that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils.
Read MorePosted by Laurie Bonner | Mar 5, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The T-Spot.Covid test is CE-marked and has been submitted for FDA emergency use authorization.
Read MorePosted by Melanie Hamilton-Basich | Mar 4, 2021 | Compliance |
COLA’s Waived Testing Toolkit provides guidance and tools to help staff achieve and maintain waived testing excellence, including guidance on covid-19 reporting.
Read MorePosted by Laurie Bonner | Mar 4, 2021 | Covid 19, Sexually Transmitted Diseases |
Increasing public awareness of the laboratory’s role in public health offers an opportunity to slow the spread of sexually transmitted infections.
Read MorePosted by Laurie Bonner | Mar 4, 2021 | Company News, Covid 19 |
Investigational detection of novel variants for positive PCR results provided to clients at no additional charge.
Read More